ADAG — Adagene Inc
On NASDAQ, Adagene Inc trades as ADAG.
Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
Searching for the Adagene Inc share price, or whether to buy ADAG? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over ADAG that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What ADAG is
Adagene Inc., a clinical-stage biopharmaceutical company, is dedicated to the research, development, and production of monoclonal antibody drugs for cancer. The company is headquartered in Suzhou, China.…
Adagene Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ADAG size and valuation
At roughly $196.7M, ADAG is a micro-cap.
Earnings per share are negative at -0.37, so there is no meaningful price-to-earnings multiple to quote.
Beta is 0.54: historically it has moved less than the market.
ADAG over the past year
Over the past year ADAG has traded between $1.30 and $4.85, and the current price sits at 20% of that range.
The 50-day average is $3.56 against a 200-day average of $3.35 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $9.91, 395.5% above it. A target is an aggregate of opinions, not a measurement.
How Adagene Inc (ADAG) is trading
Adagene Inc (ADAG) is down 0.99% at $2.00.
The session ranged from $1.93 to $2.19 — 13.0% of the share price — and the current price sits at 27% of that range.
It opened at $2.11 against a previous close of $2.02 — an opening gap of +4.5%, which almost always comes from information released outside trading hours.
Volume ran near 189.0K shares, about $378.1K of stock changing hands.
Traded alongside ADAG
Names traded alongside ADAG in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ADAG
Two statistical models run over ADAG inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: ADAG
- Name: Adagene Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ADAG — frequently asked questions
What is the market cap of ADAG?
Adagene Inc has a market capitalisation of roughly $196.7M.
What is the 52-week range for ADAG?
ADAG has traded between $1.30 and $4.85 over the past year, with the current price at 20% of that range.
How much does ADAG stock cost today?
Adagene Inc (ADAG) trades at $2.00, a change of -0.99% in the latest session.
Is ADAG up or down today?
ADAG is down 0.99% in the latest session, at $2.00.
What is the daily trading range for ADAG?
ADAG traded between $1.93 and $2.19 in the latest session, and currently trades at $2.00.
What is the trading volume for ADAG?
ADAG traded roughly 189.0K shares in the latest session.
Which exchange is ADAG listed on?
ADAG is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ADAG stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ADAG figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08